🦊/Investors

byFounders2022 Investments

5 investments dated 2022 · listed companies and verified rows first · show all

Aumioaumio.deMay 2022

Aumio Health develops science-based mobile apps for mental wellbeing and sleep across all ages, from babies to adults, built together with psychologists and tested to German healthcare-system standards.

Digital HealthMental HealthWellness & Fitness

Simon Senkl-Zieger(Founder)in

Cellocello.soin𝕏Pre-Seed · Sep 2022 · $2M

Cello provides a platform that lets SaaS companies add referral and affiliate programs to their products with a few lines of code via an SDK.

Marketing TechSaaSSales Tech

Stefan Baderin

Co-investorsFirst MomentumHeartcore Capital

Lucinitylucinity.comin𝕏Seed · Jul 2022 · $17M

Lucinity provides AI-powered financial crime prevention and anti-money laundering operations for financial institutions.

AI & Machine LearningEnterprise SoftwareFintechReykjavik, IS

GK(Founder and Executive Chairman)Daniel Pálmason(Chief Executive Officer and Co-Founder)inJohann Haraldsson(Chief Technology Officer and Co-Founder)inGuðmundur Kristjánsson(Executive Chairman and Founder)inGudmundur Kristjansson(Founder)in

Co-investorsKarma VenturesKeen Venture PartnersCrowberry Capital

Vibrantvibrant.ioinSeed · Jun 2022 · $4M

Vibrant is a fintech company working on payment solutions, including in-store payment technology.

E-commerceFintechRetail TechSaaS

Kasper Enggaard Krog(CEO & Co-Founder)inAnders Kaels Malmos(CTO & Co-Founder)inKåre Brøgger Sørensen(Chairman, CPO & Co-Founder)in

Co-investorsLuminar VenturesCiti VenturesDay One VenturesGlobivest

Watalookwatalook.cominDec 2022

Watalook provides a virtual client card system that stores customer information such as visit history, frequency, turnover, cancellations, favorite products, photos, and birthdays.

Marketing TechSaaSSales Tech

Justas Vitenas(Founder)in

Co-investorsCrosspringLaunchpad CapitalPractica CapitalStartup Wise Guys

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.